MHC-II expression to drive a unique pattern of adaptive resistance to antitumor immunity through receptor checkpoint engagement.

Justin M. Balko, Randall S. Davis, Daniel Ying Wang et al.|Journal of Clinical Oncology|2018

Cited by 9